Continental B, Lobby Level

Clearinghouses in both the U.S. and Europe are making plans to clear OTC equity options and other OTC equity derivatives. What will these plans mean for the listed options business in the U.S. and Europe? What impact will the clearing of these products have on existing OTC dealers? Will it provide opportunities for other firms to enter the OTC business as dealers? What role will the regulators play?

Chair:
Paul Zubulake, Senior Analyst, Aite Group

Speakers:
Heike Eckert, Executive Director, Head of Clearing Business Development, Eurex Clearing
Joseph Elmlinger, Managing Director & Head of Marketing, Global Futures & Derivatives Clearing Services, Bank of America Merrill Lynch
Paul Maley, Head of Listed Derivatives, Americas, Deutsche Bank
Michael McClain, Executive Vice President, Business Development and Operations, Options Clearing Corporation
John Nagel, Managing Director and General Counsel, Asset Management and Markets, Citadel
Tess Weil, Partner, Purrington Moody Weil